| SC 13D | 2020-01-10 | ELI LILLY & Co | Dermira, Inc. | 7,057,984 | 12.9% | EDGAR |
| SC 13G/A | 2019-05-03 | LILLY ELI & CO | Zymeworks Inc. | 1,545,559 | 4.8% | EDGAR |
| SC 13G/A | 2019-02-14 | LILLY ELI & CO | LEAP THERAPEUTICS, INC. | 2,632,221 | 17.9% | EDGAR |
| SC 13G/A | 2019-02-14 | LILLY ELI & CO | Zymeworks Inc. | 3,148,647 | 9.8% | EDGAR |
| SC 13G | 2019-02-14 | LILLY ELI & CO | Elanco Animal Health Inc | 293,290,000 | 80.2% | EDGAR |
| SC 13G/A | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | LILLY ELI & CO | 46,316,248 | 4.4% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | LILLY ELI & CO | 75,658,219 | 7.1% | EDGAR |
| SC 13G/A | 2019-02-04 | BlackRock Inc. | LILLY ELI & CO | 68,956,519 | 6.5% | EDGAR |
| SC 13D | 2019-01-15 | LILLY ELI & CO | Loxo Oncology, Inc. | 2,038,920 | 6.6% | EDGAR |
| SC 13G/A | 2019-01-14 | LILLY ENDOWMENT INC | LILLY ELI & CO | 118,015,304 | 11.1% | EDGAR |
| SC 13D | 2018-12-20 | LILLY ELI & CO | Dicerna Pharmaceuticals Inc | 5,414,185 | 8.6% | EDGAR |
| SC 13G/A | 2018-12-06 | PRIMECAP MANAGEMENT CO/CA/ | LILLY ELI & CO | 51,415,046 | 4.8% | EDGAR |
| SC 13G/A | 2018-05-08 | PRIMECAP MANAGEMENT CO/CA/ | LILLY ELI & CO | 54,532,393 | 5.0% | EDGAR |
| SC 13G/A | 2018-04-10 | PRIMECAP MANAGEMENT CO/CA/ | LILLY ELI & CO | 54,546,783 | 5.0% | EDGAR |
| SC 13G/A | 2018-03-07 | PRIMECAP MANAGEMENT CO/CA/ | LILLY ELI & CO | 54,755,795 | 5.0% | EDGAR |
| SC 13G/A | 2018-02-14 | LILLY ELI & CO | Zosano Pharma Corp | 1,363,636 | 3.5% | EDGAR |
| SC 13G | 2018-02-14 | LILLY ELI & CO | Zymeworks Inc. | 3,957,085 | 15.6% | EDGAR |
| SC 13G/A | 2018-02-09 | VANGUARD GROUP INC | LILLY ELI & CO | 72,222,397 | 6.6% | EDGAR |
| SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | LILLY ELI & CO | 56,663,547 | 5.2% | EDGAR |
| SC 13G/A | 2018-02-08 | PRIMECAP MANAGEMENT CO/CA/ | LILLY ELI & CO | 54,951,305 | 5.0% | EDGAR |